Zydus advances its specialty ambitions with the first generic Adempas launch in the U.S., expanding access to lower-cost pulmonary hypertension treatment.
Epcoritamab DLBCL treatment gains momentum as AbbVie and Genmab report a 51 percent reduction in progression or death risk.
Serum Institute’s WHO nod for Cervavac strengthens India’s cancer-free vision by expanding access to an indigenous HPV vaccine.
Sterile drug licensing in India could shift to CDSCO as the Centre examines central oversight following 240 NSQ injection samples in 2025-26.
Lupin Limited has launched Formoflo-G MDI, a fixed-dose triple-combination metered-dose inhaler for COPD treatment in India. The launch, announced on October 6, 2026, expands the company’s respiratory care portfolio and adds another...
Pharma giants are locking in drug discovery platforms, oral small molecules, radiopharmaceuticals, and manufacturing networks to strengthen future pipelines.
Tripura breast cancer screening is expanding as 58.2 percent of cases show distant metastasis, putting early detection and treatment access under focus.
HCG Hospital’s ‘Little Warriors, Big Dreams’ celebrated pediatric cancer survivors, families and caregivers, highlighting courage, resilience and hopeful futures.
Aurobindo Pharma CNS portfolio expands with perampanel, adding to recent epilepsy approvals as its USFDA ANDA count reaches 599.
UP hospital bills face scrutiny as medicine price gaps widen inside treatment packages, raising questions over mark-ups, discounts and patient costs.
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")
